MedPath
NMPA Approval

Regadenoson Injection

国药准字H20213800

October 26, 2021

Drug Information

瑞加诺生注射液

注射剂

5ml﹕0.4mg(按C15H18N8O5计)

化学药品

October 26, 2021

Company Information

Applicant Company

南京市江宁区联域路3号1幢304室(江宁高新园)

Manufacturing Company

南京市江北新区华康路122号3号楼

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

瑞加诺生注射液 - NMPA 批准文号 | MedPath